[The future of quinolones].
Gomis
M
M
Ledesma
F
F
D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy; D004285:Dogs; D004347:Drug Interactions; D004352:Drug Resistance, Microbial; D004363:Drug Utilization; D005544:Forecasting; D006801:Humans; D009268:Nalidixic Acid / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D000890:Anti-Infective Agents; D009268:Nalidixic Acid